Participation of CD161+ and invariant natural killer T cells in pediatric asthma exacerbations

Allergy and Asthma Proceedings

Volumn 34, Issue 1, 2013, Pages 84-92

  Carpio Pedroza, Juan C ^a,b   Vaughan, Gilberto ^a   Del Rio Navarro, Blanca E ^c   Del Rio Chivardi, Jaime M ^c   Vergara Castaneda, Arely ^d   Jimenez Zamudio, Luis A ^b   Morales Flores, Amelia ^a   Rodriguez Moreno, Guadalupe ^a   Ruiz Tovar, Karina ^a   Fonseca Coronado, Salvador ^e   Rossi, Livia M Goncalves ^a   Escobar Gutierrez, Alejandro ^a  

^a Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; FEMALE; GROUPS BY AGE; HUMAN; IMMUNE RESPONSE; INVARIANT NATURAL KILLER T CELL; MALE; NATURAL KILLER T CELL; SCHOOL CHILD;

ANTIGENS, CD4; ASTHMA; CELL SEPARATION; CHILD; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B;

EID: 84874327145     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3619     Document Type: Article

References (53)

1. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31:143-178, 2008.
2. Lemanske RF Jr, and Busse WW. Asthma: Clinical expression and molecular mechanisms. J Allergy Clin Immunol 125:S95-S102, 2010.
3. Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111:1293-1298, 2003. (Pubitemid 36683685)
4. Wark PA, and Gibson PG. Asthma exacerbations. 3: Pathogenesis. Thorax 61:909-915, 2006.
5. Jackson DJ, Sykes A, Mallia P, and Johnston SL. Asthma exacerbations: Origin, effect, and prevention. J Allergy Clin Immunol 128:1165-1174, 2011.
6. Szefler SJ. Advances in pediatric asthma in 2011: Moving forward. J Allergy Clin Immunol 129:60-68, 2012.
7. Covar RA, Szefler SJ, Zeiger RS, et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol 122:741-747, 2008.
8. Choi J, and Lee GL. Common pediatric respiratory emergencies. Emerg Med Clin North Am 30:529-563, 2012.
9. Robinson DS. The role of the T cell in asthma. J Allergy Clin Immunol 126:1081-1091, 2010.
10. Saglani S. Innate helper cells: A novel cell type essential in the initiation of asthma? Thorax 66:834-835, 2011.
11. Exley M, Porcelli S, Furman M, et al. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. J Exp Med 188:867-876, 1998. (Pubitemid 28433413)
12. González-Hernández Y, Pedraza-Sánchez S, Blandó n-Vijil V, et al. Peripheral blood CD161-T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma. Scand J Immunol 65:368-375, 2007. (Pubitemid 46481098)
13. Poggi A, Canevali P, Contatore M, and Ciprandi G. Higher frequencies of CD161 circulating T lymphocytes in allergic rhinitis patients compared to healthy donors. Int Arch Allergy Immunol 158:151-156, 2012.
14. Lanier LL, Chang C, and Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 153:2417-2428, 1994. (Pubitemid 24278110)
15. Takahashi T, Dejbakhsh-Jones S, and Strober S. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 176:211-216, 2006. (Pubitemid 43023265)
16. Godfrey DI, and Kronenberg M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J Clin Invest 114: 1379-1388, 2004. (Pubitemid 40385565)
17. Prussin C, and Foster B. TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J Immunol 159:5862-5870, 1997. (Pubitemid 127471520)
18. Hu T, Gimferrer I, Simmons A, et al. The Ras/MAPK pathway is required for generation of iNKT cells. PLoS One 6:e19890, 2011.
19. Eger KA, Sundrud MS, Motsinger AA, et al. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions. PLoS One 1:e50, 2006.
20. Kerzerho J, Yu ED, Barra CM, et al. Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties. J Immunol 188:2254-2265, 2012.
21. Godfrey DI, Hammond KJ, Poulton LD, et al. NKT cells: Facts, functions and fallacies. Immunol Today 21:573-583, 2000.
22. O'Reilly V, Zeng SG, Bricard G, et al. Distinct and overlapping effector functions of expanded human CD4-, CD8?-, and CD4-CD8?-invariant natural killer T cells. PLoS One 6:e28648, 2011.
23. Oki S, and Miyake S. Invariant natural killer T (iNKT) cells in asthma: A novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. Allergol Int 56:7-14, 2007. (Pubitemid 46449657)
24. Kronenberg M, and Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2:557-568, 2002. (Pubitemid 37328731)
25. Van Kaer L, Parekh VV, and Wu L. Invariant natural killer T cells: Bridging innate and adaptive immunity. Cell Tissue Res 343:43-55, 2011.
26. Akbari O, Faul JL, Hoyte EG, et al. CD4-invariant T-cellreceptor-natural killer T cells in bronchial asthma. N Engl J Med 354:1117-1129, 2006.
27. Meyer EH, DeKruyff RH, and Umetsu DT. iNKT cells in allergic disease. Curr Top Microbiol Immunol 314:269-291, 2007.
28. Vijayanand P, Seumois G, Pickard C, et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med. 356:1410-1422, 2007. (Pubitemid 46556326)
29. Matangkasombut P, Pichavant M, Dekruyff RH, and Umetsu DT. Natural killer T cells and the regulation of asthma. Mucosal Immunol 2:383-392, 2009.
30. Koh YI, Shim JU, Wi JO, et al. Inverse association of peripheral blood CD4(-) invariant natural killer T cells with atopy in human asthma. Hum Immunol 71:186-191, 2010.
31. Koh YI, Shim JU, Wi J, and Kwon YE. The role of natural killer T cells in the pathogenesis of acute exacerbation of human asthma. Int Arch Allergy Immunol 158:131-141, 2012.
32. Rijavec M, Volarevic S, Osolnik K, et al. Natural killer T cells in pulmonary disorders. Respir Med 105:S20-S25, 2011.
33. Bellanti J, Escobar-Gutiérrez A, Pedraza-Sánchez S, et al. Immunology IV. In Clinical Applications in Health and Disease, Chaps. 1 and 3. Bellanti J, Escobar-Gutierrez A, and Tsokas GI (Eds). Bethesda, MD: I Care Press, 3-40, 71-99, 2012.
34. Lisbonne M, Diem S, de Castro Keller A, et al. Cutting edge: Invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 171:1637-1641, 2003. (Pubitemid 36966444)
35. Holgate ST. Innate and adaptive immune responses in asthma. Nat Med 18:673-683, 2012.
36. Ho LP. Natural killer T cells in asthma-Toward increased understanding. N Engl J Med 356:1466-1468, 2007.
37. Ikegami Y, Yokoyama A, Haruta Y, et al. Circulating natural killer T cells in patients with asthma. J Asthma 41:877-882, 2004. (Pubitemid 40019140)
38. Thomas SY, Chyung YH, and Luster AD. Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma. J Allergy Clin Immunol 125: 980-984, 2010.
39. Rojas-Pandales F, Bolan os N, and Mercado M. Valores de referencia de células asesinas naturales (NK y NKT) en donantes de sangre de Bogotá . Acta Med Colombiana 32:124-128, 2007.
40. Bienemann K, Iouannidou K, Schoenberg K, et al. iNKT cell frequency in peripheral blood of Caucasian children and adolescent: The absolute iNKT cell count is stable from birth to adulthood. Scand J Immunol 74:406-411, 2011.
41. Maggi E. T-cell responses induced by allergen-specific immunotherapy. Clin Exp Immunol 161:10-18, 2010.
42. Cohavy O, Shih DQ, Doherty TM, et al. CD161 defines effector T cells that express light and respond to TL1A-DR3 signaling. Eur J Microbiol Immunol (Bp) 1:70-79, 2011.
43. Bendelac A, Savage PB, and Teyton L. The biology of NKT cells. Annu Rev Immunol 25:297-336, 2007. (Pubitemid 46697911)
44. Lambrecht BN, and Hammad H. The airway epithelium in asthma. Nat Med 18:684-692, 2012.
45. Mattner J, Debord KL, Ismail N, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-529, 2005. (Pubitemid 40477062)
46. Agea E, Russano A, Bistoni O, et al. Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med 202:295-308, 2005. (Pubitemid 41043825)
47. Wingender G, Rogers P, Batzer G, et al. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J Exp Med 208:1151-1162, 2011.
48. Edwards MR, Bartlett NW, Hussell T, et al. The microbiology of asthma. Nat Rev Microbiol 10:459-471, 2012.
49. Bartemes KR, and Kita H. Dynamic role of epithelium-derived cytokines in asthma. Clin Immunol 143:222-235, 2012.
50. Chang Y-J, Kim H, Albacker L, et al. Innate lymphoid cells mediate influenza-induced airway hyperreactivity independent of adaptive immunity. Nat Immunol 12:631-638, 2011.
51. Mjosberg J, and Spits H. Type 2 innate lymphoid cells-new members of the "type 2 franchise" that mediate allergic airway inflammation. Eur J Immunol 42:1093-1096, 2012.
52. Iwamura C, and Nakayama T. Role of NKT cells in allergic asthma. Curr Opin Immunol 22:807-813, 2010.
53. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673-680, 2002. (Pubitemid 34752477)